Annual Operating Profit
-$222.34 M
+$49.83 M+18.31%
December 31, 2023
Summary
- As of February 7, 2025, RVNC annual operating income is -$222.34 million, with the most recent change of +$49.83 million (+18.31%) on December 31, 2023.
- During the last 3 years, RVNC annual operating profit has risen by +$50.83 million (+18.61%).
- RVNC annual operating profit is now -701.55% below its all-time high of -$27.74 million, reached on December 31, 2011.
Performance
RVNC Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$32.26 M
+$2.26 M+6.55%
September 30, 2024
Summary
- As of February 7, 2025, RVNC quarterly operating income is -$32.26 million, with the most recent change of +$2.26 million (+6.55%) on September 30, 2024.
- Over the past year, RVNC quarterly operating profit has increased by +$5.31 million (+14.13%).
- RVNC quarterly operating profit is now -290.13% below its all-time high of -$8.27 million, reached on September 30, 2013.
Performance
RVNC Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$195.31 M
+$5.31 M+2.64%
September 30, 2024
Summary
- As of February 7, 2025, RVNC TTM operating income is -$195.31 million, with the most recent change of +$5.31 million (+2.64%) on September 30, 2024.
- Over the past year, RVNC TTM operating profit has increased by +$19.93 million (+9.26%).
- RVNC TTM operating profit is now -962.88% below its all-time high of -$18.38 million, reached on December 31, 2012.
Performance
RVNC TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
RVNC Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +18.3% | +14.1% | +9.3% |
| 3 y3 years | +18.6% | +55.6% | +32.9% |
| 5 y5 years | -55.9% | +24.2% | -18.8% |
RVNC Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +19.1% | at high | +60.5% | at high | +28.9% |
| 5 y | 5-year | -35.2% | +19.1% | at high | +60.5% | -18.8% | +33.9% |
| alltime | all time | -701.5% | +19.1% | -290.1% | +60.5% | -962.9% | +33.9% |
Revance Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$32.26 M(-6.5%) | -$195.31 M(-2.6%) |
| Jun 2024 | - | -$34.52 M(-26.3%) | -$200.62 M(-9.8%) |
| Mar 2024 | - | -$46.83 M(-42.7%) | -$222.45 M(+0.1%) |
| Dec 2023 | -$222.34 M(-18.3%) | -$81.72 M(+117.5%) | -$222.34 M(+3.3%) |
| Sep 2023 | - | -$37.56 M(-33.3%) | -$215.24 M(-15.6%) |
| Jun 2023 | - | -$56.35 M(+20.6%) | -$255.16 M(-0.6%) |
| Mar 2023 | - | -$46.71 M(-37.4%) | -$256.66 M(-5.7%) |
| Dec 2022 | -$272.17 M(-0.9%) | -$74.62 M(-3.7%) | -$272.17 M(+5.0%) |
| Sep 2022 | - | -$77.48 M(+34.0%) | -$259.15 M(+1.9%) |
| Jun 2022 | - | -$57.84 M(-7.0%) | -$254.39 M(-4.7%) |
| Mar 2022 | - | -$62.22 M(+1.0%) | -$266.88 M(-2.8%) |
| Dec 2021 | -$274.68 M(+0.6%) | -$61.60 M(-15.3%) | -$274.68 M(-5.6%) |
| Sep 2021 | - | -$72.72 M(+3.4%) | -$291.04 M(-1.5%) |
| Jun 2021 | - | -$70.34 M(+0.5%) | -$295.45 M(+4.7%) |
| Mar 2021 | - | -$70.01 M(-10.2%) | -$282.21 M(+3.3%) |
| Dec 2020 | -$273.16 M(+66.1%) | -$77.97 M(+1.1%) | -$273.16 M(+13.2%) |
| Sep 2020 | - | -$77.13 M(+35.1%) | -$241.36 M(+16.7%) |
| Jun 2020 | - | -$57.10 M(-6.3%) | -$206.78 M(+9.5%) |
| Mar 2020 | - | -$60.96 M(+32.0%) | -$188.79 M(+14.8%) |
| Dec 2019 | -$164.46 M(+15.3%) | -$46.17 M(+8.5%) | -$164.46 M(+5.0%) |
| Sep 2019 | - | -$42.54 M(+8.7%) | -$156.69 M(+6.0%) |
| Jun 2019 | - | -$39.12 M(+6.8%) | -$147.79 M(+2.9%) |
| Mar 2019 | - | -$36.63 M(-4.6%) | -$143.59 M(+0.7%) |
| Dec 2018 | -$142.63 M | -$38.40 M(+14.2%) | -$142.63 M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$33.64 M(-3.7%) | -$137.08 M(+2.2%) |
| Jun 2018 | - | -$34.92 M(-2.1%) | -$134.15 M(+6.4%) |
| Mar 2018 | - | -$35.66 M(+8.5%) | -$126.07 M(+7.3%) |
| Dec 2017 | -$117.50 M(+48.4%) | -$32.85 M(+7.0%) | -$117.50 M(+12.8%) |
| Sep 2017 | - | -$30.72 M(+14.4%) | -$104.20 M(+14.2%) |
| Jun 2017 | - | -$26.84 M(-0.9%) | -$91.21 M(+5.4%) |
| Mar 2017 | - | -$27.09 M(+38.5%) | -$86.50 M(+9.3%) |
| Dec 2016 | -$79.16 M(+9.5%) | -$19.55 M(+10.3%) | -$79.16 M(-2.7%) |
| Sep 2016 | - | -$17.72 M(-19.9%) | -$81.39 M(-1.3%) |
| Jun 2016 | - | -$22.14 M(+12.1%) | -$82.43 M(+7.2%) |
| Mar 2016 | - | -$19.74 M(-9.4%) | -$76.89 M(+6.3%) |
| Dec 2015 | -$72.32 M(+38.9%) | -$21.79 M(+16.1%) | -$72.32 M(+12.3%) |
| Sep 2015 | - | -$18.77 M(+13.1%) | -$64.38 M(+8.3%) |
| Jun 2015 | - | -$16.59 M(+9.3%) | -$59.44 M(+6.6%) |
| Mar 2015 | - | -$15.18 M(+9.6%) | -$55.74 M(+7.1%) |
| Dec 2014 | -$52.05 M(+36.2%) | -$13.85 M(+0.2%) | -$52.05 M(+10.4%) |
| Sep 2014 | - | -$13.82 M(+7.2%) | -$47.14 M(+13.4%) |
| Jun 2014 | - | -$12.89 M(+12.2%) | -$41.58 M(+3.9%) |
| Mar 2014 | - | -$11.49 M(+28.6%) | -$40.03 M(+4.7%) |
| Dec 2013 | -$38.23 M(-11.5%) | -$8.93 M(+8.0%) | -$38.23 M(-19.8%) |
| Sep 2013 | - | -$8.27 M(-27.1%) | -$47.67 M(+21.0%) |
| Jun 2013 | - | -$11.35 M(+17.3%) | -$39.40 M(+40.5%) |
| Mar 2013 | - | -$9.68 M(-47.3%) | -$28.05 M(+52.7%) |
| Dec 2012 | -$43.19 M(+55.7%) | -$18.38 M | -$18.38 M |
| Dec 2011 | -$27.74 M | - | - |
FAQ
- What is Revance Therapeutics annual operating income?
- What is the all time high annual operating profit for Revance Therapeutics?
- What is Revance Therapeutics annual operating profit year-on-year change?
- What is Revance Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Revance Therapeutics?
- What is Revance Therapeutics quarterly operating profit year-on-year change?
- What is Revance Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Revance Therapeutics?
- What is Revance Therapeutics TTM operating profit year-on-year change?
What is Revance Therapeutics annual operating income?
The current annual operating profit of RVNC is -$222.34 M
What is the all time high annual operating profit for Revance Therapeutics?
Revance Therapeutics all-time high annual operating income is -$27.74 M
What is Revance Therapeutics annual operating profit year-on-year change?
Over the past year, RVNC annual operating income has changed by +$49.83 M (+18.31%)
What is Revance Therapeutics quarterly operating income?
The current quarterly operating profit of RVNC is -$32.26 M
What is the all time high quarterly operating profit for Revance Therapeutics?
Revance Therapeutics all-time high quarterly operating income is -$8.27 M
What is Revance Therapeutics quarterly operating profit year-on-year change?
Over the past year, RVNC quarterly operating income has changed by +$5.31 M (+14.13%)
What is Revance Therapeutics TTM operating income?
The current TTM operating profit of RVNC is -$195.31 M
What is the all time high TTM operating profit for Revance Therapeutics?
Revance Therapeutics all-time high TTM operating income is -$18.38 M
What is Revance Therapeutics TTM operating profit year-on-year change?
Over the past year, RVNC TTM operating income has changed by +$19.93 M (+9.26%)